IXICO PLC Announces Strong Trading Update for Fiscal Year 2026

IXICO PLC reported a trading update for the fiscal year ending 30 September 2026, with revenues of £8.3 million, marking a 28% growth and surpassing previous guidance. The company's order book stands at £16.0 million, enhancing revenue visibility, while cash reserves increased to £10.4 million following a capital raise. IXICO expects to improve its loss before interest, tax, depreciation, and amortisation beyond market expectations, driven by strong demand for its neuroimaging and digital biomarker analytics services.